Archive: 18/09/2013

Drug approved for treatment of multiple sclerosis

A transformational new treatment for multiple sclerosis (MS) - the result of over three decades of research in Cambridge - was approved today by the EU agency responsible for regulating new drugs.

Shining light on neurodegenerative pathway

University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.

A storm in our veins

Suppose you're hiking through the forest on a sunny afternoon as a light breeze passes through the trees, gently grazing your skin. Suddenly the sky opens up and a rainstorm ensues. The trees keep you dry, but the weather ...

page 8 from 9